Alox12 gene is associated with the onset of natural menopause in white women

Menopause

Volumn 17, Issue 1, 2010, Pages 152-156

  Liu, Pengyuan ^a   Lu, Yan ^a   Recker, Robert R ^b   Deng, Hong Wen ^c   Dvornyk, Volodymyr ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Age at natural menopause; ALOX12; Association; Haplotypes; Polymorphisms

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ASPARAGINE; SERINE;

ADULT; ALCOHOL CONSUMPTION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BREAST FEEDING; CIGARETTE SMOKING; CONTROLLED STUDY; EARLY MENOPAUSE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGING; ARACHIDONATE 12-LIPOXYGENASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 74549129423     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181b63c68     Document Type: Article

References (60)

1. Meschia M, Pansini F, Modena AB, et al. Determinants of age at menopause in Italy: results from a large cross-sectional study. ICARUS Study Group. Italian Climacteric Research Group Study. Maturitas 2000;34: 119-125.
2. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 2006;164:1003-1011.
3. Towey M, Bundy C, Cordingley L. Psychological and social interventions in the menopause. Curr Opin Obstet Gynecol 2006;18:413-417.
4. Deeks AA. Psychological aspects of menopause management. Best Pract Res Clin Endocrinol Metab 2003;17:17-31.
5. Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000;21:167-174.
6. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14:567-571.
7. Francucci CM, Romagni P, Camilletti A, et al. Effect of natural early menopause on bone mineral density. Maturitas 2008;59:323-328.
8. Kritz-Silverstein D, Barrett-Connor E. Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health 1993;83:983-988.
9. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999;52:303-307.
10. Cramer DW. Epidemiologic aspects of early menopause and ovarian cancer. Ann N Y Acad Sci 1990;592:363-375.
11. Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 2001;98:85-90.
12. Wernli KJ, Ray RM, Gao DL, De Roos AJ, Checkoway H, Thomas DB. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 2006;17:949-955.
13. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341-354.
14. Velie EM, Nechuta S, Osuch JR. Lifetime reproductive and anthro-pometric risk factors for breast cancer in postmenopausal women. Breast Dis 2005;24:17-35.
15. Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16:556-562.
16. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
17. Murabito JM, Yang Q, Fox C, Wilson PW, Cupples LA. Heritability of age at natural menopause in the Framingham Heart Study. Obstet Gynecol Surv 2005;60:656-657.
18. He LN, Recker RR, Deng HW, Dvornyk V. A polymorphism of apo-lipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas 2009;62:37-41.
19. Hefler LA, Grimm C, Heinze G, et al. Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod 2005;20:1422-1427. (Pubitemid 40790274)
20. Long JR, Shu XO, Cai Q, et al. Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women. Maturitas 2006;55:238-246.
21. Murabito JM, Yang Q, Fox CS, Cupples LA. Genome-wide linkage analysis to age at natural menopause in a community-based sample: the Framingham Heart Study. Fertil Steril 2005;84:1674-1679. (Pubitemid 41785662)
22. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008;32:949-958.
23. Pasquali R, Casimirri F, Labate AM, et al. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord 1994;18:614-621.
24. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci 2000;904:502-506.
25. Ijuin H, Douchi T, Oki T, Maruta K, Nagata Y. The contribution of menopause to changes in body-fat distribution. J Obstet Gynaecol Res 1999;25:367-372.
26. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leuko-trienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
27. Uchide K, Sakon M, Ariyoshi H, Nakamori S, Tokunaga M, Monden M. Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S)HETE secretion; the possible role of cancer cell derived micro-particle. Ann Surg Oncol 2007;14:862-868.
28. Bednar W, Holzmann K, Marian B. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem Toxicol 2007;45:508-514.
29. Timar J, Raso E, Dome B, et al. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 2000; 87:37-43.
30. Kristensen VN, Edvardsen H, Tsalenko A, et al. Genetic variation in putative regulatory loci controlling gene expression in breast cancer. Proc Natl Acad Sci U S A 2006;103:7735-7740.
31. Mohammad AM, Abdel HA, Abdel W, Ahmed AM, Wael T, Eiman G. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy. Indian J Cancer 2006;43:163-168.
32. Natarajan R, Esworthy R, Bai W, Gu JL, Wilczynski S, Nadler J. Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor. J Clin Endocrinol Metab 1997; 82:1790-1798.
33. Jiang WG, Douglas-Jones A, Mansel RE. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prosta-glandins Leukot Essent Fatty Acids 2003;69:275-281.
34. Mullin BH, Spector TD, Curtis CC, et al. Polymorphisms in ALOX12, but not ALOX15, are significantly associated with BMD in postmeno-pausal women. Calcif Tissue Int 2007;81:10-17.
35. Ichikawa S, Koller DL, Johnson ML, et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J Bone Miner Res 2006;21:556-564.
36. Pratico D, Zhukareva V, Yao Y, et al. 12/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 2004;164:1655-1662.
37. Flatman S, Morgan A, Donald-Gibson RG, Davey A, Jonas GE, Slater TF. 12-Lipoxygenase activity in human uterine cervix. Prosta-glandins Leukot Essent Fatty Acids 1988;32:87-94.
38. Kurusu S, Jinno M, Ehara H, Yonezawa T, Kawaminami M. Inhibition of ovulation by a lipoxygenase inhibitor involves reduced cyclooxygenase-2 expression and prostaglandin E2 production in gonadotropin-primed immature rats. Reproduction 2009;137:59-66.
39. Deng HW, Xu FH, Liu YZ, et al. A whole-genome linkage scan suggests several genomic regions potentially containing QTLs underlying the variation of stature. Am J Med Genet 2002;113:29-39.
40. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
41. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63:259-266.
42. Jansen SC, Temme EH, Schouten EG. Lifetime estrogen exposure versus age at menopause as mortality predictor. Maturitas 2002;43: 105-112.
43. He LN, Xiong DH, Liu YJ, Zhang F, Recker RR, Deng HW. Association study of the oestrogen signalling pathway genes in relation to age at natural menopause. J Genet 2007;86:269-276.
44. Zhang F, Xiong DH, Wang W, et al. HDC gene polymorphisms are associated with age at natural menopause in Caucasian women. Biochem Biophys Res Commun 2006;348:1378-1382.
45. Kevenaar ME, Themmen AP, Rivadeneira F, et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod 2007;22:2382-2388.
46. Maynar M, Mahedero G, Maynar I, Maynar JI, Tuya IR, Caballero MJ. Menopause-induced changes in lipid fractions and total fatty acids in plasma. Endocr Res 2001;27:357-365.
47. Abbadia Z, Vericel E, Mathevet P, Bertin N, Panaye G, Frappart L. Fatty acid composition and CD36 expression in breast adipose tissue of premenopausal and postmenopausal women. Anticancer Res 1997;17: 1217-1221.
48. Rhee Y, Paik MJ, Kim KR, et al. Plasma free fatty acid level patterns according to cardiovascular risk status in postmenopausal women. Clin Chim Acta 2008;392:11-16.
49. Punnonen R, Seppala E, Punnonen K. Effect of ovariectomy in humans on serum 6-keto-PGF1 a and TXB2 concentrations and platelet fatty acids. Prostaglandins Leukot Med 1987;26:85-89.
50. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopauseVa five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642-647.
51. Riggs BL, Khosla S, Melton LJ III. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-773.
52. Gandy S, Duff K. Post-menopausal estrogen deprivation and Alzheimer's disease. Exp Gerontol 2000;35:503-511.
53. Alanko J, Sievi E, Lahteenmaki T, Mucha I, Vapaatalo H, Parantainen J. Catechol estrogens as inhibitors of leukotriene synthesis. Biochem Pharmacol 1998;55:101-104.
54. Ranganath LR, Christofides JA, Wright JW, Marks V. Effects of hormone replacement therapy on platelet membrane fatty acid composition. J Endocrinol 1996;148:207-212.
55. Lewis-Barned NJ, Sutherland WH, Walker RJ, et al. Plasma cholesteryl ester fatty acid composition, insulin sensitivity, the menopause and hormone replacement therapy. J Endocrinol 2000;165:649-655.
56. Guo Y, Zhang X, Tan W, et al. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Pharmacogenet Genomics 2007;17:197-205.
57. Lebeau A, Terro F, Rostene W, Pelaprat D. Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by A-amyloid peptide. Cell Death Differ 2004;11:875-884.
58. Poch E. Role of lipoxygenase metabolites in cardiovascular disease. Curr Hypertens Rep 2003;5:1-2.
59. Nozawa K, Tuck ML, Golub M, Eggena P, Nadler JL, Stern N. Inhibition of lipoxygenase pathway reduces blood pressure in renovas-cular hypertensive rats. Am J Physiol 1990;259:H1774-H1780.
60. Gonzalez-Nunez D, Claria J, Rivera F, Poch E. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 2001;37:334-338.